Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Immix Biopharma Inc.

    NASDAQ: IMMX · Real-Time Price · USD
    2.21
    0.15 (7.28%)
    At close: Jun 05, 2025, 3:59 PM
    2.20
    -0.23%
    After-hours: Jun 05, 2025, 07:57 PM EDT

    Immix Biopharma Statistics

    Share Statistics

    Immix Biopharma has 27.88M shares outstanding. The number of shares has increased by 4.95% in one year.

    Shares Outstanding

    n/a
    		 27.88M

    Shares Change (YoY)

    n/a
    		 4.95%

    Shares Change (QoQ)

    n/a
    		 0.78%

    Owned by Institutions (%)

    n/a
    		 9.76%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 133

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 213.58K, so 0.77% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 213.58K

    Short % of Shares Out

    n/a
    		 0.77%

    Short % of Float

    n/a
    		 1.3%

    Short Ratio (days to cover)

    n/a
    		 3.13

    Valuation Ratios

    The PE ratio is -2.88 and the forward PE ratio is -2.4. Immix Biopharma's PEG ratio is 0.2.

    PE Ratio

    n/a
    		 -2.88

    Forward PE

    n/a
    		 -2.4

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 4.7

    P/FCF Ratio

    n/a
    		 -3.95

    PEG Ratio

    n/a
    		 0.2
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Immix Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.08.

    Current Ratio

    n/a
    		 2.33

    Quick Ratio

    n/a
    		 2.33

    Debt / Equity

    n/a
    		 0.08

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.07

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,200,743.11

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 41.04K

    Effective Tax Rate

    n/a
    		 -0.19%

    Stock Price Statistics

    The stock price has increased by 7.28% in the last 52 weeks. The beta is 0.3, so Immix Biopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.3

    52-Week Price Change

    n/a
    		 7.28%

    50-Day Moving Average

    n/a
    		 1.9

    200-Day Moving Average

    n/a
    		 1.88

    Relative Strength Index (RSI)

    n/a
    		 53.07

    Average Volume (20 Days)

    n/a
    		 189,303

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -22.67M

    Net Income

    n/a
    		 -21.61M

    EBITDA

    n/a
    		 -21.54M

    EBIT

    n/a
    		 -21.66M

    Earnings Per Share (EPS)

    n/a
    		 -0.76
    Full Income Statement

    Balance Sheet

    The company has 17.68M in cash and 1.07M in debt, giving a net cash position of 16.61M.

    Cash & Cash Equivalents

    n/a
    		 17.68M

    Total Debt

    n/a
    		 1.07M

    Net Cash

    n/a
    		 16.61M

    Retained Earnings

    n/a
    		 -75.02M

    Total Assets

    n/a
    		 19.89M

    Working Capital

    n/a
    		 7.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.6M and capital expenditures -1.18M, giving a free cash flow of -15.77M.

    Operating Cash Flow

    n/a
    		 -14.6M

    Capital Expenditures

    n/a
    		 -1.18M

    Free Cash Flow

    n/a
    		 -15.77M

    FCF Per Share

    n/a
    		 -0.56
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    IMMX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IMMX is $7, which is 216.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 216.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.65

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist